Iris Allajbeu
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Overview of different reimbursement strategies among contrast-enhanced mammography (CEM) expert centers on a global level - A survey study.
Journal: European journal of radiology
Published: June 19, 2025
Acceptance, experience, and feedback for supplemental screening in dense breasts among women participating in the BRAID trial.
Journal: Insights into imaging
Published: May 28, 2025
Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial.
Journal: Lancet (London, England)
Published: December 21, 2024
Improving the diagnostic performance of contrast-enhanced mammography through lesion conspicuity and enhancement quantification.
Journal: European radiology
Published: October 08, 2024
Supplemental Screening With MRI in Women With Dense Breasts: The European Perspective.
Journal: Journal of breast imaging
Published: September 18, 2024
Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-13C MRI.
Journal: EJNMMI research
Published: September 12, 2024
Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.
Journal: European radiology
Published: September 02, 2024
Neoadjuvant Radiotherapy and Endocrine Therapy for Oestrogen Receptor Positive Breast Cancers: The Neo-RT Feasibility Study.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 29, 2024
Introduction of automated breast ultrasound as an additional screening tool for dense breasts in the UK: a practical approach from the BRAID trial.
Journal: Clinical radiology
Published: August 13, 2023
Deep learning-based segmentation of multisite disease in ovarian cancer.
Journal: European radiology experimental
Published: September 21, 2022
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.
Journal: Frontiers in oncology
Published: February 02, 2022
Last Updated: 09/26/2026